Walleye Trading’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Walleye Trading’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-21,800	Closed	-$1.64M	–	5779
2022 Q2	$1.64M	Buy	+21,800	New	+$969K	0.01%	1836

Walleye Trading's TPTX Position: Q3 2022 in Review

Walleye Trading sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 544 shares — an estimated $41K sold.

Walleye Trading first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $41K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Walleye Trading reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Walleye Trading sold 544 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $41K.
Walleye Trading first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Walleye Trading's Turning Point Therapeutics, Inc. Common Stock position peaked at $41K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Walleye Trading's 13F filing for Q3 2022, filed 14 Nov 2022.